Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Highway 91 Near Wilmington Avenue


Car, Truck Collide in Fatal Compton Accident 

Compton, CA (March 22, 2020) – One person was killed in a crash in Compton. The fatal accident occurred on the evening of March 22 on Highway 91.

A car and truck collided on Highway 91, near Wilmington Avenue. The car got stuck underneath the truck. Paramedics arrived and found one person dead at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Compton

#90220


March 27, 2020

1 Killed in Crash at Skyway Road and Notre Dame Boulevard

Woman Hits Retaining Wall in Fatal Chico Accident...


October 18, 2019

2-Year-Old Boy Injured in Crash on Chrysler Drive

Child Was Playing in Street Before Modesto Accident Modesto, CA (October 16, 20...


December 26, 2019

Man Killed in Crash at Sunrise Boulevard and Fitzgerald Road

Driver Runs Red Light in Fatal Rancho Cordova Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.